Agios Pharmaceuticals

Venture-backed company · Stage unknownagios.com
Rounds on record
2
Latest round
Nov 16, 2011
Form D equity offering
Latest round size
$78.0M

Public company. Publicly listed (AGIO); its private filings are not venture rounds.

More
As of · the latest observation of this company; each round carries its own date

What matters now

  1. 1 investor
    named

    1 investor on record.

    The investors already on the cap table shape who leads the next round.

    Factfunding announcements, portfolio pages and Form DFor Investors, foundersInvestors →
Drawing the relationship network…
Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
2 rounds
  1. Nov 16, 2011
    Form D equity offering · $78.0M (form d sold)
    Arch Venture Partners via Robert Taylor Nelsen
    Fact Form D · “Agios Pharmaceuticals Inc Form D, first filed 2011-11-22”
  2. Apr 14, 2010
    Form D equity offering · $8.8M (form d sold)
    Arch Venture Partners via Robert Taylor Nelsen
    Fact Form D · “Agios Pharmaceuticals Inc Form D, first filed 2010-04-26”
Investors on record
3 edges
Ownership and outcomes
none on record
No later owner or exit on record: no private equity sponsor position and no acquisition, listing or IPO report names this company.
Credit relationships
none on record
No lender position matched to this company.
People
0 officers, 0 directors
No officer or director on record.
Timeline
0 events
No dated event on record.
Evidence
3 observations
Every observation on this company
  • Listed on portfolio page: Arch Venture Partners Sep 30, 2026 Fact Firm website
  • Listed on portfolio page: Arch Venture Partners Sep 16, 2026 Fact Firm website
  • Listed on portfolio page: Arch Venture Partners Sep 14, 2026 Fact Firm website